Terkko Navigator / -/ Feeds / " ( ( Eturauhasen kasvaimet )|( Prostatan kasvaimet )|( Eturauhastuumorit )|( Prostatan sy�"

The evolving clinical use of prostate cancer biomarkers

The Improved killing of both androgen-dependent and independent prostate cancer cells with etoposide loaded SPIONs coupled with NIR irradiation

Cancers, Vol. 14, Pages 3272: Liquid Biopsy in Prostate Cancer Management—Current Challenges and Future Perspectives

Gut microbes differ in men with prostate cancer

The Spontaneous Remission of Recurrent Lymph Node Metastatic Prostate Cancer With Lowering Serum Prostate-Specific Antigen Level

The P2 purinoceptors in prostate cancer

The Effect of Irisin on Proliferation, Apoptosis, and Expression of Metastasis Markers in Prostate Cancer Cell Lines

Association of germline TYK2 variation with lung cancer and non‐Hodgkin lymphoma risk

Cancers, Vol. 14, Pages 3110: Deregulation of Cholesterol Homeostasis by a Nuclear Hormone Receptor Crosstalk in Advanced Prostate Cancer

Cancers, Vol. 14, Pages 3111: Amygdalin Exerts Antitumor Activity in Taxane-Resistant Prostate Cancer Cells

Cancers, Vol. 14, Pages 3135: Artificial Intelligence-Based Prognostic Model for Urologic Cancers: A SEER-Based Study

Pharmaceuticals, Vol. 15, Pages 806: In the Search for Novel, Isoflavone-Rich Functional Foods—Comparative Studies of Four Clover Species Sprouts and Their Chemopreventive Potential for Breast and Prostate Cancer

Cancers, Vol. 14, Pages 3184: Incidence, Mortality, and Trends of Prostate Cancer in Mexico from 2000 to 2019: Results from the Global Burden of Disease Study 2019

The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer

The prognostic significance of homologous recombination repair pathway alterations in metastatic hormone sensitive prostate cancer

A Proposal to Unify the Classification of Breast and Prostate Cancers Based on the Anatomic Site of Cancer Origin and on Long-term Patient Outcome.

Double-Negative Prostate Cancer Masquerading as a Squamous Cancer of Unknown Primary: A Clinicopathologic and Genomic Sequencing-Based Case Study.

A Proposal to Unify the Classification of Breast and Prostate Cancers Based on the Anatomic Site of Cancer Origin and on Long-term Patient Outcome

Breast cancers originating from the major lactiferous ducts and the process of neoductgenesis: Ductal Adenocarcinoma of the Breast, DAB

Cancers, Vol. 13, Pages 5464: Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?

Cancers, Vol. 12, Pages 3254: The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

Cancers, Vol. 12, Pages 3254: The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score

The evolutionary history of lethal metastatic prostate cancer.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

The effect of sample size on polygenic hazard models for prostate cancer.

The effect of sample size on polygenic hazard models for prostate cancer.

The rise of metastatic bone disease in Ireland

The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor.

The <em>CHEK2</em> Variant C.349A&gt;G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

The effect of sample size on polygenic hazard models for prostate cancer

The differential presence of human polyomaviruses, JCPyV and BKPyV, in prostate cancer and benign prostate hypertrophy tissues

Cancers, Vol. 14, Pages 1995: A Model to Detect Significant Prostate Cancer Integrating Urinary Peptide and Extracellular Vesicle RNA Data

Cancers, Vol. 14, Pages 2402: Nuclear Receptor Coregulators in Hormone-Dependent Cancers

The Global Burden of Cancer 2013.

Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals.

Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals.

Cancers, Vol. 12, Pages 2882: Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer

Cancers, Vol. 12, Pages 2882: Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer

Pre-clinical Research on Bladder Toxicity After Radiotherapy for Pelvic Cancers: State-of-the Art and Challenges

Cancers, Vol. 13, Pages 357: Estimation of the Potentially Avoidable Excess Deaths Associated with Socioeconomic Inequalities in Cancer Survival in Germany

Cancers, Vol. 13, Pages 448: Diagnosis and Treatment of Primary and Secondary Lung Cancers

The Adipose Tissue at the Crosstalk Between EDCs and Cancer Development

Cancers, Vol. 13, Pages 6305: Expression and Impact of C1GalT1 in Cancer Development and Progression